骨微环境中的PRODH2介导的新陈代谢促进乳腺癌转移
Cancer research
|August 1, 2025
概括
由PRODH2驱动的基 (Hyp) 代谢,通过促进骨质细胞分化和瘤生长,推动乳腺癌骨转移. 针对这种途径为骨转移性乳腺癌提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 代谢途径 代谢途径
- 癌症转移 癌症转移
背景情况:
- 乳腺癌经常转移到骨,治疗选择有限.
- 氨基酸代谢在骨微环境中的重编程存在潜在的治疗脆弱性.
研究的目的:
- 研究氧 (Hyp) 代谢在乳腺癌骨转移中的作用.
- 在Hyp代谢途径中确定治疗点.
主要方法:
- 从乳腺癌骨转移的临床样本的分析.
- 使用小鼠模型进行体内研究.
- 研究了proline脱酶2 (PRODH2) 的功能及其下游目标.
主要成果:
- 在临床骨转移中,PRODH2被上调,并在体内驱动骨细胞分化和骨转移.
- 在PRODH2中介的Hyp代谢上调SLC7A11和IL-8,促进瘤细胞活力和骨质细胞分化.
- PRODH2产生了乙-CoA,增强了YY1乙化和SLC7A11和IL-8的转录激活.
- 抑制PRODH2破坏了骨转移级联.
结论:
- PRODH2-Hyp轴创造了一个恶性循环,加强骨质细胞分化和乳腺癌骨转移.
- 向PRODH2-SLC7A11/IL-8轴代表了骨转移性乳腺癌的一个有希望的治疗策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


